Charmacy Pharmaceutical Co., Ltd.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
Rok finansowy 2013 2013 2014 2014 2015 2015 2016 2016 2017 2017 2018 2018 2019 2019 2020 2020 2021 2021 2022 2022 2023 2023 2024 2024
Kwartał Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4 Q2 Q4
Data 2013-06-30 2014-01-31 2014-06-30 2014-12-31 2015-06-30 2015-12-31 2016-06-30 2016-12-31 2017-06-30 2017-12-31 2018-06-30 2018-12-31 2019-06-30 2019-12-31 2020-06-30 2020-12-31 2021-06-30 2021-12-31 2022-06-30 2022-12-31 2023-06-30 2023-12-31 2024-06-30 2024-12-31
Przychód (mln) 1,648 754 1,450 1,565 1,635 1,762 1,778 1,892 1,904 2,192 2,022 1,913 1,708 1,785 1,861 2,131 1,993 1,801 1,887 2,288 2,269 2,135 2,347 2,088
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% -0.75% 133.8% 22.7% 20.9% 16.4% 24.4% 13.7% 1.1% -10.29% -18.58% -7.97% 11.4% 16.7% 0.9% 1.4% 7.4% 13.9% 18.5% 24.4% -8.74%
Marża brutto 4.2% 4.5% 4.9% 4.2% 5.1% 4.6% 5.6% 4.2% 6.6% 3.8% 7.3% 4.6% 7.8% 4.9% 6.4% 5.5% 6.6% 5.7% 6.4% 6.4% 6.1% 7.0% 7.0% 7.7%
Koszty i Wydatki (mln) 1,618 738 1,409 1,541 1,590 1,746 1,722 1,858 1,837 2,177 1,944 1,900 1,638 1,773 1,806 2,103 1,940 1,783 1,846 2,176 2,220 2,080 2,308 2,054
EBIT (mln) 28 17 40 23 42 42 53 30 68 16 81 18 72 13 56 32 56 18 44 49 52 57 39 34
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 53.3% 141.9% 33.1% 28.4% 60.3% -62.29% 51.7% -39.96% 5.7% -15.27% -30.74% 77.2% -21.71% 36.4% -20.75% 53.4% -8.06% 211.8% -11.57% -30.80%
EBIT (%) 1.9% 2.3% 2.8% 1.5% 2.6% 2.4% 3.0% 1.6% 3.6% 0.7% 4.0% 0.9% 4.2% 0.7% 3.0% 1.5% 2.8% 1.0% 2.4% 2.1% 2.3% 2.6% 1.7% 1.7%
Przychody fiansowe (mln) 17 0 8 10 12 8 7 7 9 13 14 14 12 14 13 15 19 19 15 16 14 22 0 4
Koszty finansowe (mln) -6 6 6 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 61
Amortyzacja (mln) 7 3 5 5 4 5 6 6 7 7 8 10 11 10 10 12 14 15 15 12 10 10 11 22
EBITDA (mln) 35 20 45 28 47 46 59 36 75 23 90 28 83 23 66 44 70 34 60 61 62 66 83 84
EBITDA(%) 2.3% 2.7% 3.1% 1.8% 2.9% 2.6% 3.3% 1.9% 3.9% 1.1% 4.4% 1.5% 4.9% 1.3% 3.5% 2.1% 3.5% 1.9% 3.2% 2.7% 2.7% 3.1% 3.6% 3.8%
NOPLAT (mln) 18 11 33 13 34 8 49 27 58 2 64 -1 58 -3 42 13 35 -2 26 96 35 32 39 32
Podatek (mln) 5 2 6 3 8 7 12 7 15 1 19 0 15 0 11 3 9 1 5 26 9 7 12 6
Zysk Netto (mln) 13 9 26 10 25 1 37 20 43 2 46 -0 42 -2 31 10 26 -3 21 70 26 25 27 27
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 92.5% -87.65% 39.0% 97.0% 70.1% 63.7% 24.1% -101.05% -1.43% -216.84% -32.36% 4776.0% -38.63% 30.5% -33.15% 621.2% 1.5% 989.9% 29.6% -62.00%
Zysk netto (%) 0.9% 1.2% 1.8% 0.6% 1.5% 0.1% 2.1% 1.0% 2.3% 0.1% 2.3% -0.01% 2.5% -0.12% 1.7% 0.5% 1.3% -0.16% 1.1% 3.1% 1.2% 1.2% 1.1% 1.2%
EPS -0.11 0.11 0.33 0.12 0.32 0.0135 0.34 0.18 0.4 0.017 0.42 -0.0019 0.39 -0.0199 0.29 0.0896 0.24 -0.026 0.19 0.65 0.24 0.23 0.25 0.28500000000000003
EPS (rozwodnione) -0.11 0.11 0.33 0.12 0.32 0.0135 0.34 0.18 0.4 0.017 0.42 -0.0019 0.39 -0.0199 0.29 0.0896 0.24 -0.026 0.19 0.65 0.24 0.23 0.25 0.28500000000000003
Ilośc akcji (mln) 80 80 80 82 80 83 108 108 108 108 108 108 108 108 108 108 108 108 108 108 108 108 108 108
Ważona ilośc akcji (mln) 80 80 80 82 80 83 108 108 108 108 108 108 108 108 108 108 108 108 108 108 108 108 108 108
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY